As an investigational peptide, side effects are still remaining researched, with latest trials specializing in security and efficacy.Eli Lilly formulated retatrutide as Element of its efforts to progress next-generation therapies. The drug builds about the results of before treatment plans such as GLP-one receptor agonists which include liraglutide